POMC and acromegaly: The binding affinity to SSTR5 is several times higher for PAS than it is for either OCT or LAN, which explains the increased efficacy of PAS in patients with acromegaly or Cushing’s disease, by reduction of GH and adrenocorticotropic hormone (ACTH) secretion, respectively [26, 27].